Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Hervé_Hoppenot
|
| gptkbp:focus |
oncology
inflammation autoimmunity |
| gptkbp:founded |
1991
|
| gptkbp:founder |
gptkb:Roy_Whitfield
|
| gptkbp:headquartersLocation |
gptkb:Wilmington,_Delaware,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Incyte Corporation
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Jakafi
gptkb:Opzelura gptkb:Pemazyre |
| gptkbp:numberOfEmployees |
over 2000
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:revenue |
$3.4 billion (2023)
|
| gptkbp:servesArea |
worldwide
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:INCY
|
| gptkbp:subsidiary |
gptkb:Incyte_Biosciences_International_Sàrl
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
https://www.incyte.com/
|
| gptkbp:bfsParent |
gptkb:parsaclisib
gptkb:^NDX gptkb:Jakafi |
| gptkbp:bfsLayer |
6
|